600216 浙江医药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额1,488,6661,223,299634,311520,6031,136,656
投资活动产生之现金流量净额(243,029)(473,500)(518,591)(971,154)(983,693)
筹资活动产生之现金流量净额(367,648)(255,321)(141,430)43,91469,754
汇率变动对现金及现金等价物的影响55,42611,26847,64076,015(79,839)
现金及现金等价物净增加/(减少)933,415505,74621,930(330,622)142,878
期初现金及现金等价物余额1,965,5851,459,8401,437,9091,768,5321,625,654
期末现金及现金等价物余额2,899,0001,965,5851,459,8401,437,9091,768,532